Skip to main content
. 2020 Apr 6;9(7):e014070. doi: 10.1161/JAHA.119.014070

Table 1.

Characteristics of CHS Participants Free of CVD at 1992–1993 Examination, by FABP‐4

FABP‐4, ng/mL (N=4026)
≤22.36 >22.36 to 29.92 >29.92 to 40.64 >40.64
n 1008 1009 1009 1000
FABP‐4, ng/mL 18.0 26.2 34.7 58.1
Age, y 74.6±4.9 74.6±5.2 74.7±5.4 74.8±5.3
Male 72.2% 44.4% 25.0% 13.0%
Black 13.4% 15.6% 16.7% 21.5%
Field center
North Carolina 26.2% 28.1% 28.8% 22.3%
California 26.4% 28.9% 23.9% 29.1%
Maryland 19.0% 18.9% 21.7% 23.8%
Pennsylvania 28.4% 24.0% 25.6% 24.8%
Body mass index, kg/m2 24.5±3.5 26.0±3.9 27.2±4.1 29.9±5.7
Waist circumference, cm 92.0±10.7 95.5±12.1 97.9±12.3 104.1±15.5
Systolic BP, mm Hg 134.9±20.9 135.3±20.7 136.6±21.2 138.4±21.7
Diastolic BP, mm Hg 72.0±11.3 71.6±11.0 71.8±10.8 70.8±12.0
Heart rate 63.4±10.8 65.2±10.4 65.9±10.3 68.1±11.6
Grip strength, kg 32.8±10.7 28.2±9.7 25.3±8.9 23.7±7.6
LDL‐cholesterol, mg/dL 114.8±31.4 119.0±32.4 122.7±33.7 123.4±37.0
Triglycerides, mg/dL 116.5±66.8 134.1±73.5 148.4±82.8 167.2±93.9
HDL‐cholesterol, mg/dL 53.8±14.7 54.5±15.0 54.8±14.3 53.2±13.9
C‐reactive protein, mg/L 3.9±9.8 4.5±7.1 5.0±8.9 7.8±12.2
Fibrinogen, mg/dL 311.5±62.2 323.0±62.2 325.9±62.8 349.4±75.5
eGFRcys 81.5±16.9 76.8±16.8 73.2±17.3 63.6±17.9
Alcoholic beverages/wk 3.1±6.4 2.3±5.3 1.8±5.4 1.3±7.9
Total physical activity, kcal 1864.6±2047.7 1496.0±1783.0 1401.8±1710.5 1033.7±1332.9
Antihypertensive medication 34.6% 42.8% 48.4% 60.8%
Prevalent diabetes mellitus 10.4% 12.0% 13.4% 19.3%
Smoking status
Never 37.7% 42.7% 53.3% 53.5%
Former 51.2% 45.6% 37.2% 38.3%
Current 11.1% 11.7% 9.5% 8.2%
Self‐reported health
Excellent 9.4% 7.9% 7.6% 4.0%
Very good 38.0% 35.1% 31.5% 26.0%
Good 38.3% 40.5% 43.4% 44.6%
Fair 13.2% 15.0% 16.7% 22.2%
Poor 1.1% 1.5% 0.8% 3.1%

BP indicates blood pressure; CHS, Cardiovascular Health Study; CVD, cardiovascular disease; FABP‐4, fatty acid binding protein‐4; eGFR, estimated glomerular filtration rate; HDL, high‐density lipoprotein; and LDL, low‐density lipoprotein.